[Relationship Between Symptom Distress and Fatigue in Hepatocellular Carcinoma XXXX Who Received Transcatheter Arterial Embolization].

@entity1 @entity96 @entity5 @entity1416 @entity1295 @entity490 @entity221
BACKGROUND: The @entity1295 and symptom distress of @entity5 @entity1 have been researched extensively. However, few studies have focused on the @entity1295 and symptom distress experienced by @entity96 @entity1 following tran-scatheter @entity1416 (TAE) treatment. PURPOSE: This study explores the levels of symptom distress and @entity1295 in @entity96 @entity1 and related factors. METHODS: This cross-sectional study used purposive sampling to recruit 100 @entity96 @entity1 who had received TAE treatment from a medical center in southern Taiwan. Structured questionnaires were used to collect the data from the first, second, and third days following the TAE treatment. RESULTS: Notable reductions in @entity1295 and symptom distress levels were observed in post-TAE-treatment @entity1 . The 5 main symptoms were @entity490 , @entity1295 , @entity221 . Factors identified as influencing the level of @entity1295 were marital status, family members' accompaniment during the TAE treatment, physical performance status, age, and symptom distress. CONCLUSIONS / IMPLICATIONS FOR PRACTICE: Physicians treating @entity96 @entity1 should better explain to @entity1 the symptoms and @entity1295 associated with TAE treatment. Physicians should also provide interventions that may reduce the related symptoms, @entity1295 levels, and mental distress.
